Skip to main content
Clinical Trials/DRKS00010033
DRKS00010033
Completed
N/A

Efficacy of Integrated Social Cognitive and Behavioral Skills Therapy (ISST) inImproving Functional Outcome in Schizophrenia - ISST2015

Klinik und Poliklinik für Psychiatrie und Psychotherapie,Heinrich-Heine-Universität0 sites177 target enrollmentMarch 10, 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
DSM-IV-TR: 295.10-30, 295.90
Sponsor
Klinik und Poliklinik für Psychiatrie und Psychotherapie,Heinrich-Heine-Universität
Enrollment
177
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 10, 2016
End Date
February 4, 2021
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Klinik und Poliklinik für Psychiatrie und Psychotherapie,Heinrich-Heine-Universität

Eligibility Criteria

Inclusion Criteria

  • Written informed consent
  • \- DSM\-IV\-TR diagnosis of schizophrenia (295\.10\-30, 295\.90\)
  • \- PANSS at baseline: total score \= 75
  • \- Age between 18 and 65 years
  • \- Proficiency in German language.
  • \- Individualized medication according to valid treatment guidelines with up to two antipsychotic substances with flexible dosage and mode of administration within recommended dose ranges. With this medication, patients must have been treated for at least 2 weeks prior to enrollment to ensure that the maximum effect of the medication has been achieved. The addition of low\- and medium\-potent antipsychotic substances as a need medication for the treatment of restlessness and sleep disorders is possible, provided that the daily dosage of 150 chlorpromazine (CPZ) units is not exceeded.

Exclusion Criteria

  • Lack of accountability
  • \- Positive urine drug\-screening for illicit drugs at screening (except cannabinoids and benzodiazepines)
  • \- Serious suicidal risk at screening visit
  • \- Other relevant axis 1\-diagnoses according to diagnostic interview (MINI);
  • \- Other relevant neurological or somatic disorders
  • \- Verbal IQ\<80 (MWT\-B)

Outcomes

Primary Outcomes

Not specified

Similar Trials